Dexcom (DXCM) EBITDA Margin (2010 - 2026)
Dexcom (DXCM) posted quarterly EBITDA Margin of 24.33% for Q2 2026, up 595.0% year-over-year from 3.5% in Q2 2025, and up 13.58% quarter-over-quarter from 21.42% in Q1 2026.
Dexcom (DXCM) EBITDA Margin (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported EBITDA Margin for 17 consecutive years, with 24.33% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA Margin rose 595.0% year-over-year to 24.33%; the TTM figure through Jun 2026 stood at 22.92% (up 694.0% YoY), while the FY2025 annual figure was 19.56%, up 468.0% from the prior year.
- EBITDA Margin advanced to 24.33% in Q2 2026 per DXCM's latest filing, from 21.42% in the prior quarter.
- Across five years, EBITDA Margin topped out at 25.64% in Q4 2025 and bottomed at 6.37% in Q1 2023.
- Historically, EBITDA Margin has averaged 16.5% across 5 years, with a median of 16.35% in 2024.
- On a YoY basis, EBITDA Margin climbed as much as 1530 bps in 2022 and fell as far as 591 bps in 2022.
- Dexcom's EBITDA Margin stood at 15.38% in 2022, then soared by 36 bps to 20.97% in 2023, then declined by 19 bps to 16.96% in 2024, then soared by 51 bps to 25.64% in 2025, then decreased by 5 bps to 24.33% in 2026.
- Business Quant data shows DXCM's EBITDA Margin at 24.33% in Q2 2026, 21.42% in Q1 2026, and 25.64% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.33% |
| Mar 31, 2026 | 21.42% |
| Dec 31, 2025 | 25.64% |
| Sep 30, 2025 | 20.05% |
| Jun 30, 2025 | 18.37% |
| Mar 31, 2025 | 12.91% |
| Dec 31, 2024 | 16.96% |
| Sep 30, 2024 | 15.29% |
| Jun 30, 2024 | 15.73% |
| Mar 31, 2024 | 10.98% |
| Dec 31, 2023 | 20.97% |
| Sep 30, 2023 | 21.08% |
| Jun 30, 2023 | 14.70% |
| Mar 31, 2023 | 6.37% |
| Dec 31, 2022 | 15.38% |
| Sep 30, 2022 | 19.17% |
| Jun 30, 2022 | 11.06% |
| Mar 31, 2022 | 6.57% |
| Dec 31, 2021 | 0.09% |
| Sep 30, 2021 | 18.19% |